These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24782504)

  • 1. Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome.
    Martínez-Trillos A; Pinyol M; Navarro A; Aymerich M; Jares P; Juan M; Rozman M; Colomer D; Delgado J; Giné E; González-Díaz M; Hernández-Rivas JM; Colado E; Rayón C; Payer AR; Terol MJ; Navarro B; Quesada V; Puente XS; Rozman C; López-Otín C; Campo E; López-Guillermo A; Villamor N
    Blood; 2014 Jun; 123(24):3790-6. PubMed ID: 24782504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.
    Shuai W; Lin P; Strati P; Patel KP; Routbort MJ; Hu S; Wei P; Khoury JD; You MJ; Loghavi S; Tang Z; Fang H; Thakral B; Medeiros LJ; Wang W
    Blood Cancer J; 2020 Aug; 10(8):86. PubMed ID: 32848129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
    Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
    Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL.
    Improgo MR; Tesar B; Klitgaard JL; Magori-Cohen R; Yu L; Kasar S; Chaudhary D; Miao W; Fernandes SM; Hoang K; Westlin WF; Kim HT; Brown JR
    Br J Haematol; 2019 Mar; 184(6):925-936. PubMed ID: 30537114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
    Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
    Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
    Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
    Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.
    Mongini PK; Gupta R; Boyle E; Nieto J; Lee H; Stein J; Bandovic J; Stankovic T; Barrientos J; Kolitz JE; Allen SL; Rai K; Chu CC; Chiorazzi N
    J Immunol; 2015 Aug; 195(3):901-23. PubMed ID: 26136429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
    Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
    J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysis.
    Cao Y; Chen Y; Tao T; Gong Y; Xu C; Cen J; Shen H; Pan J; Chen S; Yao L
    Int J Lab Hematol; 2023 Dec; 45(6):908-916. PubMed ID: 37551448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
    Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
    Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia.
    Giménez N; Schulz R; Higashi M; Aymerich M; Villamor N; Delgado J; Juan M; López-Guerra M; Campo E; Rosich L; Seiffert M; Colomer D
    Leukemia; 2020 Jan; 34(1):100-114. PubMed ID: 31197259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia.
    Ali YB; Foad RM; Abdel-Wahed E
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3245-3250. PubMed ID: 29286214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene.
    Qin SC; Xia Y; Miao Y; Zhu HY; Wu JZ; Fan L; Li JY; Xu W; Qiao C
    Blood Cancer J; 2017 Dec; 7(12):651. PubMed ID: 29242635
    [No Abstract]   [Full Text] [Related]  

  • 14. A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
    Hernández JÁ; Hernández-Sánchez M; Rodríguez-Vicente AE; Grossmann V; Collado R; Heras C; Puiggros A; Martín AÁ; Puig N; Benito R; Robledo C; Delgado J; González T; Queizán JA; Galende J; de la Fuente I; Martín-Núñez G; Alonso JM; Abrisqueta P; Luño E; Marugán I; González-Gascón I; Bosch F; Kohlmann A; González M; Espinet B; Hernández-Rivas JM;
    PLoS One; 2015; 10(11):e0143073. PubMed ID: 26630574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of
    Ahn A; Kim HS; Kim TY; Lee JM; Kang D; Yu H; Lee CY; Kim Y; Eom KS; Kim M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of MYD88 mutations in CLL: the jury is still out.
    Baliakas P; Hadzidimitriou A; Agathangelidis A; Rossi D; Sutton LA; Kminkova J; Scarfo L; Pospisilova S; Gaidano G; Stamatopoulos K; Ghia P; Rosenquist R
    Blood; 2015 Aug; 126(8):1043-4. PubMed ID: 26294719
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
    Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
    J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
    Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
    Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
    Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
    Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.